Search results
Results will auto-populate based on filter selection.
973
Found 973 result(s)
21-02-03
Policy
All claim file information is considered personal information under the Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed in…
21-02-05
Policies
All claim file information is considered personal information under The Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed…
21-02-04
Policy
All claim file information is considered personal information under The Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed in…
21-02-06
Policy
All claim file information is considered personal information under the Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed in…
15-04-07
Policy
Where the worker is seriously and permanently disfigured about the face or neck, the WSIB may allow a lump sum in compensation, which is separate and distinct from a…
Update July 26, 2023 The first phase of our consultation began on June 8, 2023 and closed on July 21, 2023. We appreciate all the feedback received, which overwhelmingly…
Each year, we are required under the Workplace Safety and Insurance Act to conduct a value-for-money audit. The latest audit focused on the dispute resolution, appeals and…
12-04-14
Law
s.2(1)
Full-time domestic workers are covered under Schedule 1 of the Act.
Policy
The WSIB provides coverage for domestic workers who are employed more than 24 hours…
On this page: 1. Introduction 1.1. Background 2. Occupational disease legislative and policy scheme…
The Drug Advisory Committee was established in 2007 to guide WSIB on which drugs to include in our drug benefit plan as well as the medical conditions and criteria needed for…
Each year, we are required under the Workplace Safety and Insurance Act (WSIA) to have an external firm review the cost, efficiency, and effectiveness of one of our programs…
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A Indication(s) OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
Corticosteroid injections in musculoskeletal conditions Indications/Clinical uses Treatment of acute and chronic musculoskeletal conditions including neck and upper…
18-04-15
Policy
If the WSIB concludes, through a non-economic loss (NEL) determination, see 18-05-03, Determining…
18-04-09
Policy
A worker may elect to receive an amount equal to the full monthly pension for Old Age Security (OAS), instead of a future economic loss (FEL) benefit, if the worker…
Toronto, November 25, 2020 - The WSIB is pleased to announce that Elizabeth Witmer has been reappointed Chair of the Board of Directors of Ontario’s WSIB for a fourth term…
Toronto, May 19, 2020 – The WSIB is pleased to announce that Elizabeth Witmer has been reappointed Chair of the Board of Directors of Ontario’s WSIB for a third term. …
12-04-03
Policy
An authority who summons a person to assist in controlling or extinguishing a fire is deemed the person's employer.
The Crown is deemed the employer of a person who…
12-01-02
Law
s.74(1)
Upon application, the WSIB may declare an employer to be deemed a Schedule 1 employer for purposes of the insurance plan.
Policy
An employer may apply for…
18-01-12
Policy
When an injured worker meets the relevant eligibility criteria set out in the Workplace Safety and Insurance Act or the Workers' Compensation Act…